Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07171164 · ClinicalTrials.gov registry record · NA
A Study to Evaluate Community-Based Measures to Increase RSV Vaccine Use Among Latino Adults
A NA study of Older Adults Without Any Specific Clinical Condition and Social Networks, sponsored by University of California, San Francisco.
- Recruiting
- Registry status
- NA
- Development phase
- 750
- Enrollment target
- 1
- Study location
NCT07171164: Recruiting NA study of Older Adults Without Any Specific Clinical Condition and Social Networks, sponsored by University of California, San Francisco.
NCT07171164 is a NA study of Older Adults Without Any Specific Clinical Condition and Social Networks that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 750 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (47% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07171164, a NA study of Older Adults Without Any Specific Clinical Condition and Social Networks, is actively recruiting participants, sponsored by University of California, San Francisco.
- RECRUITING
- Registry status
- NA
- Development phase
- 750 participants
- Enrollment target
- 1
- Study location
Study Summary
In collaboration with community-based organizations, this study will focus on increasing RSV vaccine use among Latinos. The study will determine how effective community health worker counseling and text-message approaches are to (1) increase RSV vaccine use among older adults (Motivate phase) and (2) encourage younger adults to discuss RSV vaccination with their older friends and family members (Activate phase).
Primary Outcome
RSV vaccine uptake at 60 days per California Immunization Registry (CAIR) or per medical record
Conditions Studied
Interventions
- BEHAVIORAL Motivate Aim: CHW text message reminders and counseling
- BEHAVIORAL Motivate Aim: CHW text message reminders only
- BEHAVIORAL Activate Aim: CHW text message reminders and counseling
- BEHAVIORAL Activate Aim: CHW text message reminders only
Study Locations (1)
California
- University of California, San Francisco - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 750 participants |
| Start Date | 2025-09-10 |
| Est. Completion | 2028-11 |
| Phase | NA |
What NCT07171164 shows while recruiting
NCT07171164 is an interventional study that assigns participants to a tested intervention. The registered 750 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (47% lower).
The record links to 4 conditions, with Older Adults Without Any Specific Clinical Condition appearing as the primary indexed condition, and to 4 interventions - of which Motivate Aim: CHW text message reminders and counseling is the first listed.
NCT07171164 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT07171164 about?
NCT07171164 is a clinical study titled "A Study to Evaluate Community-Based Measures to Increase RSV Vaccine Use Among Latino Adults". In collaboration with community-based organizations, this study will focus on increasing RSV vaccine use among Latinos. The study will determine how effective community health worker counseling and text-message approaches are to (1) increase RSV vaccine use among older adults (Motivate phase) and (2...
What is the current status of trial NCT07171164?
This trial is currently recruiting. It is a NA study. The enrollment target is 750 participants. The study started on 2025-09-10. Estimated completion is 2028-11.
What conditions does trial NCT07171164 study?
This clinical trial studies the following conditions: Older Adults Without Any Specific Clinical Condition, Social Networks, RSV Immunization, Vaccine Uptake.
What interventions are being tested in trial NCT07171164?
The interventions under investigation include: Motivate Aim: CHW text message reminders and counseling (BEHAVIORAL), Motivate Aim: CHW text message reminders only (BEHAVIORAL), Activate Aim: CHW text message reminders and counseling (BEHAVIORAL), Activate Aim: CHW text message reminders only (BEHAVIORAL).
Who is sponsoring clinical trial NCT07171164?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07171164 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07171164's enrollment target sits among peer trials
750 145th of 2000 higher than 1,856 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02048332 · 750 participants · Phase 1
Donor-Derived Viral Specific T-cells (VSTs)
- NCT02087852 · 750 participants
Kidney Cancer DNA Registry
- NCT02532452 · 750 participants · Phase 2
Third Party Viral Specific T-cells (VSTs)
- NCT03126916 · 750 participants · Phase 3
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI